BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19644728)

  • 1. Polyunsaturated fatty acids protect against prion-mediated synapse damage in vitro.
    Bate C; Tayebi M; Salmona M; Diomede L; Williams A
    Neurotox Res; 2010 Apr; 17(3):203-14. PubMed ID: 19644728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docosahexaenoic and eicosapentaenoic acids increase neuronal death in response to HuPrP82-146 and Abeta 1-42.
    Bate C; Marshall V; Colombo L; Diomede L; Salmona M; Williams A
    Neuropharmacology; 2008 May; 54(6):934-43. PubMed ID: 18355880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glimepiride protects neurons against amyloid-β-induced synapse damage.
    Osborne C; West E; Nolan W; McHale-Owen H; Williams A; Bate C
    Neuropharmacology; 2016 Feb; 101():225-36. PubMed ID: 26432105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells.
    Bate C; Tayebi M; Diomede L; Salmona M; Williams A
    BMC Biol; 2008 Sep; 6():39. PubMed ID: 18789130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase A2 inhibitors protect against prion and Abeta mediated synapse degeneration.
    Bate C; Tayebi M; Williams A
    Mol Neurodegener; 2010 Apr; 5():13. PubMed ID: 20374666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vitro model for synaptic loss in neurodegenerative diseases suggests a neuroprotective role for valproic acid via inhibition of cPLA2 dependent signalling.
    Williams RS; Bate C
    Neuropharmacology; 2016 Feb; 101():566-75. PubMed ID: 26116815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol protects cultured neurons against amyloid-β and α-synuclein-induced synapse damage.
    Bate C; Williams A
    Neuropharmacology; 2011 Dec; 61(8):1406-12. PubMed ID: 21903110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-β(1-40) inhibits amyloid-β(1-42) induced activation of cytoplasmic phospholipase A2 and synapse degeneration.
    Bate C; Williams A
    J Alzheimers Dis; 2010; 21(3):985-93. PubMed ID: 20634578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines.
    Bate C; Tayebi M; Diomede L; Salmona M; Williams A
    PLoS One; 2009 Dec; 4(12):e8221. PubMed ID: 20011040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cytosolic Phospholipase A2 prevents prion peptide-induced neuronal damage and co-localisation with Beta III Tubulin.
    Last V; Williams A; Werling D
    BMC Neurosci; 2012 Aug; 13():106. PubMed ID: 22928663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of phospholipase A2 increased the removal of the prion derived peptide PrP82-146 from cultured neurons.
    Bate C; Ingham V; Williams A
    Neuropharmacology; 2011; 60(2-3):365-72. PubMed ID: 20934441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A glycosylphosphatidylinositol analogue reduced prion-derived peptide mediated activation of cytoplasmic phospholipase A2, synapse degeneration and neuronal death.
    Bate C; Tayebi M; Williams A
    Neuropharmacology; 2010; 59(1-2):93-9. PubMed ID: 20398681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-β-induced synapse damage is mediated via cross-linkage of cellular prion proteins.
    Bate C; Williams A
    J Biol Chem; 2011 Nov; 286(44):37955-37963. PubMed ID: 21900234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclo-oxygenase inhibitors protect against prion-induced neurotoxicity in vitro.
    Bate C; Rutherford S; Gravenor M; Reid S; Williams A
    Neuroreport; 2002 Oct; 13(15):1933-8. PubMed ID: 12395095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nonfibrillar form of the fusogenic prion protein fragment [118-135] induces apoptotic cell death in rat cortical neurons.
    Pillot T; Drouet B; Pinçon-Raymond M; Vandekerckhove J; Rosseneu M; Chambaz J
    J Neurochem; 2000 Dec; 75(6):2298-308. PubMed ID: 11080181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effect of cellular prion protein (PrPC) is related with activation of alpha7 nicotinic acetylcholine receptor (α7nAchR)-mediated autophagy flux.
    Jeong JK; Park SY
    Oncotarget; 2015 Sep; 6(28):24660-74. PubMed ID: 26295309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal and transynaptic spread of prions.
    Shearin H; Bessen RA
    J Virol; 2014 Aug; 88(15):8640-55. PubMed ID: 24850738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation.
    Xiao Y; Li X
    Brain Res; 1999 Oct; 846(1):112-21. PubMed ID: 10536218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of cellular prion protein (PrP(C)) prevents cognitive dysfunction and apoptotic neuronal cell death induced by amyloid-β (Aβ₁₋₄₀) administration in mice.
    Rial D; Piermartiri TC; Duarte FS; Tasca CI; Walz R; Prediger RD
    Neuroscience; 2012 Jul; 215():79-89. PubMed ID: 22537845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-synuclein induced synapse damage is enhanced by amyloid-β1-42.
    Bate C; Gentleman S; Williams A
    Mol Neurodegener; 2010 Dec; 5():55. PubMed ID: 21138585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.